Investment Research Partners’s Medpace MEDP Stock Holding History

Investment Research Partners’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-394	Closed	-$221K	–	256
2025 Q4	$221K	Buy	+394	New	+$224K	0.1%	211

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Investment Research Partners's MEDP Position: Q1 2026 in Review

Investment Research Partners sold out of Medpace (MEDP) in Q1 2026, closing a stake of 394 shares — an estimated $221K sold.

Investment Research Partners first reported a position in MEDP in Q4 2025 and held it in 1 quarter. The position peaked at $221K in Q4 2025. 734 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Investment Research Partners reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
Investment Research Partners sold 394 Medpace shares in Q1 2026, an estimated $221K.
Investment Research Partners first reported a position in Medpace in Q4 2025 and held it in 1 quarter.
Investment Research Partners's Medpace position peaked at $221K in Q4 2025.
734 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Investment Research Partners's 13F filing for Q1 2026, filed 29 Apr 2026.